Recce (Australia) Today
| RCE Stock | 0.46 0.01 2.13% |
Performance2 of 100
| Odds Of DistressLess than 24
|
Recce is selling for under 0.46 as of the 31st of January 2025; that is 2.13 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.46. Recce has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 11th of February 2023 and ending today, the 31st of January 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Recce Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Recce's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Recce or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | James GAICD |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Recce (RCE) is traded on Australian Securities Exchange in Australia and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 107.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Recce's market, we take the total number of its shares issued and multiply it by Recce's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Recce operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 231.87 M outstanding shares.
Recce generates negative cash flow from operations
Check Recce Probability Of Bankruptcy
Ownership AllocationRecce owns a total of 231.87 Million outstanding shares. Recce has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Recce Ownership Details
Recce Risk Profiles
Although Recce's alpha and beta are two of the key measurements used to evaluate Recce's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.27 | |||
| Semi Deviation | 2.55 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.71 |
Recce Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Recce without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Recce Corporate Management
Elected by the shareholders, the Recce's board of directors comprises two types of representatives: Recce inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Recce. The board's role is to monitor Recce's management team and ensure that shareholders' interests are well served. Recce's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Recce's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Justin Reynolds | Chief Officer | Profile | |
| Arthur Kollaras | Principal Manufacturing | Profile | |
| BA BCom | Head Marketing | Profile | |
| John Prendergast | Executive Board | Profile | |
| Maggie Niewidok | Company Secretary | Profile |
Additional Tools for Recce Stock Analysis
When running Recce's price analysis, check to measure Recce's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce is operating at the current time. Most of Recce's value examination focuses on studying past and present price action to predict the probability of Recce's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce's price. Additionally, you may evaluate how the addition of Recce to your portfolios can decrease your overall portfolio volatility.